Biologic Agents—A Panacea for Inflammatory Arthritis or Not?

Aim. To describe the retention rates for biological therapies in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS) in a clinical setting. Methods. All patients managed in a dedicated biological therapy clinic in a teaching hospital in Australia were...

Descripción completa

Detalles Bibliográficos
Autores principales: Ninan, J., Smith, Malcolm D., Dugar, M., O'Brien, Karen, Ahern, Michael
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814094/
https://www.ncbi.nlm.nih.gov/pubmed/20130798
http://dx.doi.org/10.1155/2009/420759